GREGG HALVERSON: Open Payments
NPI 1033776539 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 49 payments from 12 companies in 2025. Trend: 2023 $674 · 2024 $1,159 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $208 |
| Supernus Pharmaceuticals, Inc. | 11 | $147 |
| Otsuka America Pharmaceutical, Inc. | 9 | $144 |
| Janssen Pharmaceuticals, Inc | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Almatica Pharma LLC | 2 | $39 |
| Corium, LLC | 3 | $34 |
| Alkermes, Inc. | 1 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
Products named: VRAYLAR, Qelbree, ABILIFY ASIMTUFII, CAPLYTA, REXULTI, Auvelity, INVEGA SUSTENNA, SPRAVATO.
Industry payments across FL — which companies pay providers there.
